|1.||Yun, Hyo-In: 1 article (02/2007)|
|2.||Kim, Myoung-Seok: 1 article (02/2007)|
|3.||Park, Byung-Kwon: 1 article (02/2007)|
|4.||Hwang, Mi-Hyun: 1 article (02/2007)|
|5.||Lim, Jong-Hwan: 1 article (02/2007)|
|6.||Park, Seung-Chun: 1 article (02/2007)|
|7.||Hwang, Youn-Hwan: 1 article (02/2007)|
|8.||Cho, Jae Youl: 1 article (06/2006)|
|9.||Yun, Hyo In: 1 article (06/2006)|
|10.||Kim, Sung Dae: 1 article (06/2006)|
|1.||Septic Shock (Toxic Shock Syndrome)
02/05/2007 - "Surfactin C not only completely bound to the LPS (its median effective concentration being 13.75 microM) but also improved the survival and reduced of the number of inoculated bacteria in the mouse model of septic shock. "
02/05/2007 - "To evaluate the anti-endotoxin activity of surfactin C, we studied its lipopolysaccharide-binding activity in vitro and therapeutic efficacy in experimental models of gram-negative septic shock. "
02/05/2007 - "Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock."
02/05/2007 - "Surfactin C reduced the plasma endotoxin, tumor necrosis factor-alpha and nitric oxide levels in response to septic shock in rats."
|3.||Cardiovascular Diseases (Cardiovascular Disease)
|1.||Urokinase-Type Plasminogen Activator (Urokinase)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Nitric Oxide (Nitrogen Monoxide)